LGC (Cambridge, UK) has developed a COVID-19 antibody assay that can analyze up to 40,000 samples daily and is suitable for…
Browsing: Research > Clinical
Infectious Diseases Hub has partnered with Future Virology to bring you exclusive access to articles and features in the recent Special Focus Issue.
AstraZeneca and Oxford University (UK) have resumed the progress of their Phase III COVID-19 vaccine trial after investigating unexpected side effects in a patient enrolled in the trial in the UK.
In an exclusive interview with an author behind one of the papers published in the recent Future Virology Special Focus Issue, heptatitis and COVID-19 are discussed.
By investigating the lung microbiome we can increase our understanding and therefore treatment avenues for CF lung infections.
In this Commentary article published in the Special Focus Issue in Future Virology on the COVID-19 pandemic, researchers study the safety of different populations in regard to the spread of disease.
COVID-19 patients who develop a cytokine storm in response to infection could be unable to produce memory cells that provide long-term protection against SARS-CoV-2.
In this Special Report from the ‘COVID-19: studying the global pandemic’ Special Focus Issue authors theorize about the identification of asymptomatic patients and the impact this has on the spread of COVID-19.
An epidemiological study has revealed that COVID-19 outcomes are better in those countries that have undertaken a TB vaccination regime in the last 15 years.